Select a Meeting...
- SHM Converge 2025
- SHM Converge 2024
- SHM Converge 2023
- SHM Converge 2022
- SHM Converge 2021
- Hospital Medicine 2020, Virtual Competition
- Hospital Medicine 2019, March 24-27, National Harbor, Md.
- Hospital Medicine 2018; April 8-11; Orlando, Fla.
- Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
- Hospital Medicine 2016, March 6-9, San Diego, Calif.
- Hospital Medicine 2015, March 29-April 1, National Harbor, Md.
- Hospital Medicine 2014, March 24-27, Las Vegas, Nev.
- Hospital Medicine 2013, May 16-19, National Harbor, Md.
- Hospital Medicine 2012, April 1-4, San Diego, Calif.
- Hospital Medicine 2011, May 10-13, Dallas, Texas.
- Hospital Medicine 2010, April 8-11, Washington, D.C.
- Hospital Medicine 2009, May 14-17, Chicago, Ill.
- Hospital Medicine 2008, April 3-5, San Diego, Calif.
- Hospital Medicine 2007, May 23-25, Dallas, Texas
- Hospital Medicine 2006, May 3-5, Washington, D.C.
Meetings Archive For Hospital Medicine 2020, Virtual Competition..
Abstract Number: 156
Hospital Medicine 2020, Virtual Competition
Background: We have presented our experience with a novel percutaneous approach for axillary artery implant of intra-aortic balloon pumps. The axillary approach permits up-right posture and ambulation, but such enhanced mobility may predispose to higher risk of IABP malposition with unique complications. We present a few complications here. Methods: We conducted a retrospective review of [...]
Abstract Number: 157
Hospital Medicine 2020, Virtual Competition
Background: There is literature to suggest there is a subtype of COPD patients in which eosinophils may play an important role. Data suggests that this subset of patient are more prone to develop exacerbations, but also have a higher likelihood of responding to inhaled corticosteroid therapy. The objective of this study is to determine if [...]
Abstract Number: 158
Hospital Medicine 2020, Virtual Competition
Background: Ceftriaxone or cefotaxime has been the drug of choice to treat spontaneous bacterial peritonitis (SBP) for many years, but little is known about microbiology, resistance rate to cephalosporines, and clinical outcomes over the last few decades. Our study aimed to describe the clinical and microbiological characteristics of culture-positive SBP at University of Kentucky Hospital. [...]
Abstract Number: 159
Hospital Medicine 2020, Virtual Competition
Background: Sepsis is one of the most common causes for adult emergency department admissions and carries high morbidity and mortality. Appropriate and timely administration of intravenous (IV) antibiotics is one of the cornerstones of initial management of sepsis. Indeed, mortality has been shown to increase by 7-14% for each hour of delay in antibiotic administration. [...]
Abstract Number: 160
Hospital Medicine 2020, Virtual Competition
Background: Over 5 million people in the United States are diagnosed with heart failure (HF) and many continue to be hospitalized for exacerbations of this disease. An estimated 20 million Americans have been diagnosed with some form of thyroid disease. Thyroid hormones significantly impact cardiac muscle functions and elevated levels of thyroxine (T4), as seen [...]
Abstract Number: 161
Hospital Medicine 2020, Virtual Competition
Background: With the rising prevalence of persons who inject drugs, we are increasingly confronted with the challenge of managing them in the hospital setting as they are at an increased risk of leaving the hospital prematurely. There is limited data on the factors associated with leaving against medical advice (AMA) in persons who inject drugs [...]
Abstract Number: 162
Hospital Medicine 2020, Virtual Competition
Background: The obesity paradox describes a counterintuitive observation of improved outcomes in patients with obesity. Analysis of the association among overweight/obesity and leading causes of inpatient mortality in a systemic manner has not been conducted. Methods: We used STATA (StataCorp, College Station, Texas) to analyze the 2016 National Inpatient Sample (NIS). We recognized patients with [...]
Abstract Number: 163
Hospital Medicine 2020, Virtual Competition
Background: Low serum concentrations of tetracycline antibiotics may raise concerns on their efficacy in patients with secondary bacteremia, especially in comorbid patients and in those with higher acuity of illness. Omadacycline (OMC), an aminomethylcycline antibiotic, showed non-inferiority to linezolid (LZD) in two acute bacterial skin and skin structure infections (ABSSSI) studies (Omadacycline in Acute Skin [...]
Abstract Number: 164
Hospital Medicine 2020, Virtual Competition
Background: The risk for serious infections and poor treatment outcomes is reported to be higher in patients with diabetes compared to the general population. Omadacycline (OMC) is an intravenous (IV) and oral aminomethylcycline antibiotic approved in the US to treat acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults. [...]
Abstract Number: 165
Hospital Medicine 2020, Virtual Competition
Background: Palliative care in seriously ill patients has been shown in some studies to improve satisfaction, symptoms, inpatient mortality rates, healthcare utilization and cost. While inpatient palliative care has been shown to improve symptoms and quality of life measures, the literature on its association with 30-day readmissions have been mixed for heart failure hospitalizations. We [...]